Thematic photoMartin FalbisonerCC BY-SA 3.0Resized, encoded as WebP; displayed with responsive cropping under the original licenceSEC EDGAR published this disclosure on 2026-08-21. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001193125-26-361183
acquired disposedA
codeA
direct or indirectI
form4
is derivativetrue
issuer nameMedline Inc.
labelGrant or award
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001193125-26-361183",
"acquired_disposed": "A",
"code": "A",
"direct_or_indirect": "I",
"form": "4",
"is_derivative": true,
"issuer_name": "Medline Inc.",
"label": "Grant or award",
"person_name": "Boyle James M",
"price": null,
"role": "Director, Chief Executive Officer",
"security": "Incentive Units of Medline Holdings, LP",
"shares": 764252,
"shares_owned_after": 764252,
"source_path": "edgar/data/2061052/0001193125-26-361183.txt",
"ticker": "MDLN",
"transaction_date": "2026-08-19",
"value": null
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.